CA2035492A1 - Ventilation/lavage liquide des poumons - Google Patents

Ventilation/lavage liquide des poumons

Info

Publication number
CA2035492A1
CA2035492A1 CA002035492A CA2035492A CA2035492A1 CA 2035492 A1 CA2035492 A1 CA 2035492A1 CA 002035492 A CA002035492 A CA 002035492A CA 2035492 A CA2035492 A CA 2035492A CA 2035492 A1 CA2035492 A1 CA 2035492A1
Authority
CA
Canada
Prior art keywords
liquid
ventilation
biologically active
perfluorocarbon
pulmonary system
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA002035492A
Other languages
English (en)
Other versions
CA2035492C (fr
Inventor
K. Michael Sekins
Thomas H. Shaffer
Marla R. Wolfson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Alliance Pharmaceutical Corp
Temple University of Commonwealth System of Higher Education
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US07/495,817 external-priority patent/US5158536A/en
Application filed by Individual filed Critical Individual
Priority to CA002332618A priority Critical patent/CA2332618A1/fr
Publication of CA2035492A1 publication Critical patent/CA2035492A1/fr
Application granted granted Critical
Publication of CA2035492C publication Critical patent/CA2035492C/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B8/00—Diagnosis using ultrasonic, sonic or infrasonic waves
    • A61B8/42—Details of probe positioning or probe attachment to the patient
    • A61B8/4272—Details of probe positioning or probe attachment to the patient involving the acoustic interface between the transducer and the tissue

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
CA002035492A 1990-03-19 1991-02-01 Ventilation/lavage liquide des poumons Expired - Fee Related CA2035492C (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CA002332618A CA2332618A1 (fr) 1990-03-19 1991-02-01 Ventilation/lavage liquide des poumons

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US495,817 1990-03-19
US07/495,817 US5158536A (en) 1989-08-28 1990-03-19 Lung cancer hyperthermia via ultrasound and/or convection with perfiuorochemical liquids

Related Child Applications (1)

Application Number Title Priority Date Filing Date
CA002332618A Division CA2332618A1 (fr) 1990-03-19 1991-02-01 Ventilation/lavage liquide des poumons

Publications (2)

Publication Number Publication Date
CA2035492A1 true CA2035492A1 (fr) 1991-09-20
CA2035492C CA2035492C (fr) 2001-03-27

Family

ID=23970103

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002035492A Expired - Fee Related CA2035492C (fr) 1990-03-19 1991-02-01 Ventilation/lavage liquide des poumons

Country Status (1)

Country Link
CA (1) CA2035492C (fr)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0650378A1 (fr) * 1992-07-16 1995-05-03 Temple University of the Commonwealth System of Higher Education Traitement de conditions physiologiques avec un liquide a base de perfluorocarbone degaze
EP1208851A3 (fr) * 1991-11-14 2003-05-07 Alliance Pharmaceutical Corporation Médicament pour administration pulmonaire
US7726311B2 (en) 2002-11-29 2010-06-01 Universite De Sherbrooke Method and apparatus for conducting total liquid ventilation with control of residual volume and ventilation cycle profile
CN114098699A (zh) * 2021-11-05 2022-03-01 中国科学院精密测量科学与技术创新研究院 一种用于小动物磁共振灌注成像的实验床
CN115006800A (zh) * 2021-03-04 2022-09-06 上海增欣机电科技股份有限公司 一种可视化排痰呼吸训练器

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1208851A3 (fr) * 1991-11-14 2003-05-07 Alliance Pharmaceutical Corporation Médicament pour administration pulmonaire
EP0650378A1 (fr) * 1992-07-16 1995-05-03 Temple University of the Commonwealth System of Higher Education Traitement de conditions physiologiques avec un liquide a base de perfluorocarbone degaze
EP0650378A4 (fr) * 1992-07-16 1995-07-12 Univ Temple Traitement de conditions physiologiques avec un liquide a base de perfluorocarbone degaze.
US7726311B2 (en) 2002-11-29 2010-06-01 Universite De Sherbrooke Method and apparatus for conducting total liquid ventilation with control of residual volume and ventilation cycle profile
CN115006800A (zh) * 2021-03-04 2022-09-06 上海增欣机电科技股份有限公司 一种可视化排痰呼吸训练器
CN114098699A (zh) * 2021-11-05 2022-03-01 中国科学院精密测量科学与技术创新研究院 一种用于小动物磁共振灌注成像的实验床

Also Published As

Publication number Publication date
CA2035492C (fr) 2001-03-27

Similar Documents

Publication Publication Date Title
CA2090404A1 (fr) Suspensions d'un vehicule pour l'administration d'un medicament fluore non aqueux
EP0037992A1 (fr) Liquide cérébrospinal, méthode de fabrication d'un tel liquide et appareil destiné à sa mise en oeuvre
CA2198916A1 (fr) Administration de compositions medicamenteuses solides
KR870006893A (ko) 고점성 하이드로겔 또는 그 현탁액의 약학적 제제
AU3275689A (en) Process for stabilizing human albumin solutions and the solution obtained
ATE113650T1 (de) Ausgewählte stämme von lactobacillus enthaltende pharmazeutische zusammensetzungen.
KR970703130A (ko) 플루티카손 프로피오네이트 제제(Fluticasone Propionate Formulations)
CA2343123A1 (fr) Concentre de principe actif contenant du formoterol, pouvant etre stocke
IT1243745B (it) Composizioni terapeutiche transdermali contenenti farmaco e/o agente promotore dell'assorbimento cutaneo supportato su particelle microporose e microsfere polimeriche e loro preparazione.
US4758431A (en) Extravascular circulation of oxygenated synthetic nutrients to treat tissue hypoxic and ischemic disorders
HK1021622A1 (en) Preparation for the transport of an active substance across barriers
CA2035492A1 (fr) Ventilation/lavage liquide des poumons
SE8400723L (sv) Farmaceutisk komposition
DE69329340D1 (de) Aufbewahren von stammzellen
ATE104146T1 (de) Zubereitung mit verzoegerter freigabe eines hydrochlorids eines basischen arzneistoffs.
SE9403905D0 (sv) New formulations
Chi et al. Hydroxyethyl starch solution attenuates blood-brain barrier disruption caused by intracarotid injection of hyperosmolar mannitol in rats
ATE132877T1 (de) Emulgatorfreie emulsionspolymere in pharmazeutischen zubereitungen mit verzögerter wirkstofffreigabe und ihre herstellung
WO1996020719A3 (fr) Solution de substitution pour liquide organique
Nordback et al. Acute effects of a nucleoside analog dideoxyinosine (DDI) on the pancreas
Sakaguchi et al. Lipid Peroxide Formation and Membrane Damage in Endotoxicosis.
Grimble et al. Nifuratel for trichomonal vaginitis.
CA2036592A1 (fr) Agent therapeutique pour la gangrene diabetique
Mitskovski et al. [Efficiency of some fungicides in controlling the parasite, Peronospora tabacini in tobacco plantations].[Macedonian]
Zinnemann Haemophilus aphrophilus endocarditis.

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed